These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 15117325)

  • 21. Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1.
    Meunier JC; Engle RE; Faulk K; Zhao M; Bartosch B; Alter H; Emerson SU; Cosset FL; Purcell RH; Bukh J
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4560-5. PubMed ID: 15767578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term persistence of infection in chimpanzees inoculated with an infectious hepatitis C virus clone is associated with a decrease in the viral amino acid substitution rate and low levels of heterogeneity.
    Fernandez J; Taylor D; Morhardt DR; Mihalik K; Puig M; Rice CM; Feinstone SM; Major ME
    J Virol; 2004 Sep; 78(18):9782-9. PubMed ID: 15331711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection.
    Lehmann M; Meyer MF; Monazahian M; Tillmann HL; Manns MP; Wedemeyer H
    J Med Virol; 2004 Jul; 73(3):387-91. PubMed ID: 15170633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Profound suppression of chronic hepatitis C following superinfection with hepatitis B virus.
    Coffin CS; Mulrooney-Cousins PM; Lee SS; Michalak TI; Swain MG
    Liver Int; 2007 Jun; 27(5):722-6. PubMed ID: 17498260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro replication models for the hepatitis C virus.
    Sheehy P; Mullan B; Moreau I; Kenny-Walsh E; Shanahan F; Scallan M; Fanning LJ
    J Viral Hepat; 2007 Jan; 14(1):2-10. PubMed ID: 17212638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A critical role for the chimpanzee model in the study of hepatitis C.
    Bukh J
    Hepatology; 2004 Jun; 39(6):1469-75. PubMed ID: 15185284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunization of chimpanzees with an envelope protein-based vaccine enhances specific humoral and cellular immune responses that delay hepatitis C virus infection.
    Puig M; Major ME; Mihalik K; Feinstone SM
    Vaccine; 2004 Feb; 22(8):991-1000. PubMed ID: 15161076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of steroids on hepatitis C virus replication in vivo and in vitro.
    Henry SD; Metselaar HJ; Van Dijck J; Tilanus HW; Van Der Laan LJ
    Ann N Y Acad Sci; 2007 Sep; 1110():439-47. PubMed ID: 17911459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infection of B cells with hepatitis C virus for the development of lymphoproliferative disorders in patients with chronic hepatitis C.
    Inokuchi M; Ito T; Uchikoshi M; Shimozuma Y; Morikawa K; Nozawa H; Shimazaki T; Hiroishi K; Miyakawa Y; Imawari M
    J Med Virol; 2009 Apr; 81(4):619-27. PubMed ID: 19235854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Practical use of hepatitis C virus kinetics monitoring in the treatment of chronic hepatitis C.
    Chevaliez S; Pawlotsky JM
    J Viral Hepat; 2007 Nov; 14 Suppl 1():77-81. PubMed ID: 17958647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell culture and infection system for hepatitis C virus.
    Kato T; Date T; Murayama A; Morikawa K; Akazawa D; Wakita T
    Nat Protoc; 2006; 1(5):2334-9. PubMed ID: 17406476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Infection of tupaia hepatocytes with hepatitis C virus in vitro].
    Zhao XP; Tian ZF; Chen YC; Yang C; Tian DY; Yang DL; Hao LJ
    Zhonghua Gan Zang Bing Za Zhi; 2005 Nov; 13(11):805-7. PubMed ID: 16313720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virology and pathogenesis of hepatitis C virus recurrence.
    Ramírez S; Pérez-Del-Pulgar S; Forns X
    Liver Transpl; 2008 Oct; 14 Suppl 2():S27-35. PubMed ID: 18825723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Host response to hepatitis C virus.
    Mihm S
    Hepatology; 2005 Mar; 41(3):679. PubMed ID: 15723317
    [No Abstract]   [Full Text] [Related]  

  • 35. Correlation of in vivo infectivity of hepatitis C virus to in vitro infectivity and to virion properties.
    Yoshikura H; Hijikata M; Nakajima N; Wang M; Mizuno K; Rikihisa T; Ueno T; Nishimura S; Shimizu Y
    Princess Takamatsu Symp; 1995; 25():139-42. PubMed ID: 8875618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals.
    Valcavi P; Medici MC; Casula F; Arcangeletti MC; De Conto F; Pinardi F; Calderaro A; Chezzi C; Dettori G
    J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental models for hepatitis C viral infection.
    Boonstra A; van der Laan LJ; Vanwolleghem T; Janssen HL
    Hepatology; 2009 Nov; 50(5):1646-55. PubMed ID: 19670425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-time PCR assays for hepatitis C virus (HCV) RNA quantitation are adequate for clinical management of patients with chronic HCV infection.
    Halfon P; Bourlière M; Pénaranda G; Khiri H; Ouzan D
    J Clin Microbiol; 2006 Jul; 44(7):2507-11. PubMed ID: 16825372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-level hepatitis C viremia and humoral immune response to NS4 in chronic hepatitis B virus-hepatitis C virus coinfection.
    Chu CM; Sheen IS; Liaw YF
    Scand J Gastroenterol; 2004 Aug; 39(8):778-82. PubMed ID: 15513365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiviral CD8-mediated responses in chronic HCV carriers with HBV superinfection.
    Boni C; Amadei B; Urbani S; Fisicaro P; Zerbini A; Mori C; Missale G; Bertoni R; Azzurri A; Del Prete G; Ferrari C
    Hepatology; 2004 Aug; 40(2):289-99. PubMed ID: 15368433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.